Skip to main content
. 2023 Jul 7;26(1):153–163. doi: 10.1093/neuonc/noad119

Figure 4.

Figure 4.

Overall survival in patients with pseudoprogression by trial arm (A). Overall survival in patients without pseudoprogression by trial arm (B).